Filippine, sospeso il vaccino contro la febbre dengue

Protesters display placards during a rally outside the Department of Health to demand accountability to Government officials involved in the controversial immunization of  the anti-dengue vaccine Dengvaxia to more than 700,000 Filipino children Tuesday, Dec. 5, 2017 in Manila, Philippines. The controversial vaccine, manufactured by Sanofi Pasteur was put on hold by the Philippines last week after new study findings showed it posed risks of severe cases in people without previous infection. The drug was recalled Tuesday from local health centers. The sign reads: Investigate The 3.5 Billion-Peso Dengvaxia Project.! (AP Photo/Bullit Marquez)
A Manila Health offricer displays a pair of vials of the anti-dengue vaccine Dengvaxia after being recalled from local government health centers Tuesday, Dec. 5, 2017 in Manila, Philippines. The controversial vaccine, manufactured by Sanofi Pasteur and administered to more than 700,000 Filipino children, was put on hold by the Philippines last week after new study findings showed it posed risks of severe cases in people without previous infection. (AP Photo/Bullit Marquez)
A Manila Health offricer puts back into the refrigerated storage, boxes of the anti-dengue vaccine Dengvaxia after being recalled from local government health centers Tuesday, Dec. 5, 2017 in Manila, Philippines. The controversial vaccine, manufactured by Sanofi Pasteur and administered to more than 700,000 Filipino children, was put on hold by the Philippines last week after new study findings showed it posed risks of severe cases in people without previous infection. (AP Photo/Bullit Marquez)
Protesters burn caricatures of, from left, former President Gloria Macapagal Arroyo, President Rodrigo Duterte and former President Benigno Aquino III, during a rally outside the Department of Health to demand accountability to Government officials involved in the controversial immunization of  the anti-dengue vaccine Dengvaxia to more than 700,000 Filipino children Tuesday, Dec. 5, 2017 in Manila, Philippines. The controversial vaccine, manufactured by Sanofi Pasteur was put on hold by the Philippines last week after new study findings showed it posed risks of severe cases in people without previous infection. The drug was recalled Tuesday from local health centers. (AP Photo/Bullit Marquez)
Protesters shout slogans during a rally outside the Department of Health to demand accountability to Government officials involved in the controversial immunization of  the anti-dengue vaccine Dengvaxia to more than 700,000 Filipino children Tuesday, Dec. 5, 2017 in Manila, Philippines. The controversial vaccine, manufactured by Sanofi Pasteur was put on hold by the Philippines last week after new study findings showed it posed risks of severe cases in people without previous infection. The drug was recalled Tuesday from local health centers. The sign in center reads: Investigate The 3.5 Billion-Peso Dengvaxia Project.! (AP Photo/Bullit Marquez)
A Manila Health offricer scoops empty vials of the anti-dengue vaccine Dengvaxia inside the vaccine storage room Tuesday, Dec. 5, 2017 in Manila, Philippines. The controversial vaccine, manufactured by Sanofi Pasteur and administered to more than 700,000 Filipino children, was put on hold by the Philippines last week after new study findings showed it posed risks of severe cases in people without previous infection. The drug was recalled Tuesday from local health centers following the controversy. (AP Photo/Bullit Marquez)

Dopo l’immunizzazione di massa a più di 700 mila bambini filippini, il controverso vaccino contro la febbre dengue, prodotto dalla Sanofi Pasteur, è stato sospeso la settimana scorsa. I nuovi risultati di uno studio hanno dimostrato che rappresenta un rischio di casi gravi in persone senza precedente infezione e che quindi protegge solo chi è già stato colpito dalla malattia. Le autorità del Paese hanno aperto un’inchiesta e il farmaco è stato ritirato martedì scorso dai centri sanitari locali. Tutto questo però ha generato dissensi e rabbia sfociati in manifestazioni davanti al Dipartimento della Salute per chiedere la responsabilità ai funzionari governativi coinvolti.

Secondo l’Organizzazione mondiale della sanità, la dengue causa circa 50 milioni di casi ogni anno in tutto il mondo, la maggior parte dei quali si verificano nei continenti del sud del pianeta, in particolare nelle zone tropicali e subtropicali. (foto Ap)

Guarda anche

Esteri
Fedeli in festa per Buddha

Fedeli in festa per Buddha

di
Esteri
Un pasto di solidarietà

Un pasto di solidarietà

di
Esteri
L’equinozio in terra Maya

L’equinozio in terra Maya

di
Esteri
La Russia alle urne

La Russia alle urne

di
Giornata internazionale della donna
È l’8 marzo in tutto il mondo

È l’8 marzo in tutto il mondo

di

I più visti della settimana

Esteri
Fedeli in festa per Buddha

Fedeli in festa per Buddha

di
Esteri
I colori dell’India

I colori dell’India

di
Esteri
L’11 settembre del Cile

L’11 settembre del Cile

di
Paesi
La Cina corre più veloce

La Cina corre più veloce

A cura di
Paesi
Festa della Luna in Vietnam

Festa della Luna in Vietnam

di
Paesi
La festa del Vesak

La festa del Vesak

di
Edicola Digitale Città Nuova - Reader Scarica l'app
Simple Share Buttons